NDC directory

epinephrine

Gland Pharma Limited · INJECTION

68083-701ANDAAdrenergic alpha-Agonists [MoA]
Product NDC
68083-701
Generic name
epinephrine
Labeler name
Gland Pharma Limited
Brand name
epinephrine
Finished
true
Listing expiration date
20271231
Marketing category
ANDA
Dosage form
INJECTION
SPL ID
cff9d22e-947e-497f-a58b-635e55434623
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261026
Product ID
68083-701_cff9d22e-947e-497f-a58b-635e55434623
Application number
ANDA220400
Brand name base
epinephrine
Active ingredients
  1. Name
    EPINEPHRINE
    Strength
    1 mg/mL
Packaging
  1. Package NDC
    68083-701-01
    Description
    1 VIAL in 1 CARTON (68083-701-01) / 30 mL in 1 VIAL
    Marketing start date
    20261026
    Sample
    false
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Pharm class
Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.